[1] |
Yi Peng, Li Cuiling, Huang Xinjiang, Zeng Chunhua.
Clinical analysis of 5 cases with precocious puberty caused by hypothalamic hamartomas treated with gonadotropin releasing hormone analogues
[J]. Clinical Focus, 2024, 39(1): 53-56.
|
[2] |
Tao Jianan, Li Wenqian, Ma Xiuwen, An Qi, Wang Xuehong.
Meta-analysis of expression and clinical significance of HER-2 in hepatocellular carcinoma
[J]. Clinical Focus, 2023, 38(12): 1067-1072.
|
[3] |
Zhang Na, Sun Yue, Dong Han, Zhao Peng, Yang Xin, Qi Yuan, Wang Lingling.
Correlation between the expression level of SPARC and prognosis in patients with non-small cell lung cancer: A meta-analysis
[J]. Clinical Focus, 2023, 38(11): 972-978.
|
[4] |
Liu Fei, Lin Zhichun, Yue Jianlan, Yin Liang, Huang Shiming.
Meta-analysis of different positron emission tomography/computed tomography imaging agents in the diagnosis of gliomas
[J]. Clinical Focus, 2023, 38(4): 302-307.
|
[5] |
.
[J]. Clinical Focus, 2023, 38(3): 273-278.
|
[6] |
He Chendong, Ge Fenglin, Yang Wei.
TFEB translocation renal cell carcinoma: A case and literature review
[J]. Clinical Focus, 2022, 37(12): 1122-1126.
|
[7] |
Jia Chengbang, Shen Lijuan, Sun Zhigang.
The relationship between CEA, CA125 and NSE and the pathological characteristics of patients with NSCLC and the value of combined detection
[J]. Clinical Focus, 2022, 37(11): 992-995.
|
[8] |
He Chao, Huang Shaobin.
Predicting the risk by FIB-4 on hepatocellular carcinoma in patients with chronic liver disease: A meta-analysis
[J]. Clinical Focus, 2022, 37(9): 779-784.
|
[9] |
Peng Yu, Jiang Zhihong, Wang Zhihai.
Clinical and genetic analysis of a neonate with congenital central nervous system multiple malformation: An identification on mutations in VANGL1 genes
[J]. Clinical Focus, 2022, 37(7): 640-643.
|
[10] |
.
[J]. Clinical Focus, 2022, 37(7): 653-657.
|
[11] |
.
[J]. Clinical Focus, 2022, 37(7): 663-667.
|
[12] |
.
[J]. Clinical Focus, 2022, 37(6): 564-567.
|
[13] |
Li Qing, Zhong Wen, Liu Siqiang, Chen Yusheng, Li Hongru.
Meta-analysis of PD-1/PD-L1 inhibitors in the treatment of patients with non-small cell lung cancer having brain metastases
[J]. Clinical Focus, 2022, 37(5): 400-405.
|
[14] |
.
[J]. Clinical Focus, 2021, 36(8): 765-768.
|
[15] |
He Yiwen, Qiao Tiankui.
Clinical value of CEA, CA125, and CYFRA21-1 levels in efficacy evaluation of EGFR-TKIs in the treatment of EGFR mutation-positive non-small cell lung adenocarcinoma
[J]. Clinical Focus, 2021, 36(3): 220-224.
|